Repurposing approved drugs as ferroptosis modulators: a critical review of clinical trials in cancer and neurodegeneration
Fields of Study & Subjects
Ferroptosis and cancer prognosis
Trace Elements in Health
Clusterin in disease pathology
Publication details
- Journal / source
- Naunyn-Schmiedeberg s Archives of Pharmacology
- Publisher
- Springer Science and Business Media LLC
- Volume
- 399
- Issue
- 12
- Pages
- 18655–18672
- Publication date
- 19 June 2026
- Language
- EN